Agomab Therapeutics NV (AGMB): SCHEDULE 13G filed Mar 6, 2026

Form type

SCHEDULE 13G

Filing date

Mar 6, 2026

Accession number

0000315066-26-000646

Filer

Agomab Therapeutics NV (CIK 2020932)